MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3

MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
复制标题

MicroRNA-125b 通过靶向 E2F3 抑制膀胱癌的发展

DOI:
10.1002/ijc.25509
复制
发表时间:
2011-04-15
影响因子:
6.4
通讯作者:
Lin, Tianxin
Lin, Tianxin
中科院分区:
医学1区
文献类型:
--
作者:
Huang, Li;Luo, Junhua;Lin, Tianxin

文献摘要

被引文献

相似文献

越来越多的证据表明,某些microRNA(miRNAs)的失调可能有助于肿瘤的发生。microRNA-125 b(miR-125 b)与细胞增殖和分化密切相关,在多种肿瘤中表达下调。然而,miR-125 b在膀胱肿瘤发生中的生物学功能仍然未知。在我们的研究中,我们发现miR-125 b在膀胱癌组织和四种膀胱癌细胞系中的表达显著降低。此外,miR-125 b在体外可抑制膀胱癌细胞的集落形成和裸鼠体内成瘤。E2 F3是miR-125 b的靶基因,在大多数低分化膀胱癌中过表达,是G1/ S转换的关键基因。在膀胱癌组织和细胞系中检测到E2 F3 mRNA和蛋白表达水平,有趣的是,在膀胱癌组织和4种E2 F3非扩增细胞系中发现miR-125 b和E2 F3蛋白水平呈负相关。miR-125 b的导入可降低E2 F3蛋白的表达,但对E2 F3 mRNA的表达无影响。此外,我们观察到转染miR-125 b可以抑制Cyclin A2的表达,Cyclin A2是参与G1/ S转换的E2 Fs应答基因之一。这些结果表明miR-125 b可能通过E2 F3-Cyclin A2信号通路调控G1/ S转换。总之,miR-125 b可能在膀胱尿路上皮中起肿瘤抑制剂的作用,并且miR-125 b的下调可能有助于膀胱癌的肿瘤发生。
Increasing evidence has suggested that dysregulation of certain microRNAs (miRNAs) may contribute to tumorigenesis. microRNA- 125b (miR-125b) was implicated to have close relationship with cell proliferation and differentiation, and downregulation of miR-125b was observed in various types of cancers. However, the biological function of miR-125b in bladder tumorigenesis is still unknown. In our study, we showed that the expression of miR-125b was significantly decreased in bladder cancer tissues and four bladder cancer cell lines. Moreover, miR-125b could suppress bladder cancer cells to form colonies in vitro and to develop tumors in nude mice. E2F3, which was critical for G1/ S transition and was overexpressed in most of poor-differentiated bladder cancers, was identified as a target of miR-125b by luciferase assay. The E2F3 mRNA and protein expression levels were detected in bladder cancer tissues and cell lines, and interestingly, inverse correlations between miR-125b and E2F3 protein level were found in bladder cancer tissues and four E2F3 nonamplified cell lines. Introduction of miR-125b could reduce the expression of E2F3 protein but not the E2F3 mRNA. In addition, we observed that transfection of miR-125b could inhibit the expression of Cyclin A2, one of the E2Fs-responsive genes involved in G1/ S transition. These results suggest that miR-125b may regulate G1/ S transition through the E2F3-Cyclin A2 signaling pathway. Taken together, miR-125b may act as a tumor suppressor in bladder urothelium, and downregulation of miR-125b may contribute to the tumorigenesis of bladder cancer.